Listar DMed - Artículos por financiación

Mostrando ítems 1-15 de 15

      Financiación
      Takeda Pharmaceutical Company Ltd [1]
      Takeda to the European Respiratory Society (ERS). [1]
      Tenure-track Clinician Scientist Fellowship (MR/N008324/1) [1]
      The authors would like to acknowledge support from the Research Department of the Costa del Sol Hospital. [1]
      The “NUTRAOLEUM Study” has been supported by the grant ITC-20131031 from the I+D FEDER-INTERCONNECTA (CDTI) and Junta de Andalucía, Spain. We thank ACER CAMPESTRES S.L., SAN FRANCISCO DE ASIS Coop. And., and AGROINSUR S.L., for the funding provided. We appreciate the support received from the workers of the clinical trials unit of the “Virgen de las Nieves” and “San Cecilio” hospitals by finding subjects for the study and for their involvement in the intervention; we thank Laura Campaña Martín, Maria Victoria Martín Laguna and Mª Cruz Rico Prados who carried out technical work, sample preparation and biomarker analyses, and Llenalia Garcia Fernández, who supervised the statistical analysis. [1]
      The “NUTRAOLEUM Study” has been supported by the grant ITC-20131031 from the I+D FEDER-INTERCONNECTA (CDTI) and Junta de Andalucía, Spain”. [1]
      This study was financially supported by an unrestricted grant from Laboratorios Menarini, SA (Barcelona, Spain). [1]
      This work was partially supported by grants from the W. Alton Jones Foundation, EPA-CR 820301, NIH-CA-13410, and NSF-DCB-9105594. The assistance of The Center for Reproductive Research at Tufts University (P30 HD 28897) is gratefully acknowledged. [1]
      This work was partially supported by Grants IT-795-13 and IT-472-07 from the Basque Department of Education (http://www.hezkuntza.ejgv.euskadi.net/r4​3-2591/es). TV is supported by the FPI Program of the University of Basque Country (UPV-EHU, http://www.ehu.es/p200-home/es). [1]
      This work was supported by a grant from Harvard-Portugal Program HMSP-ICS/SAU-ICT/0002/2010. Daniel H. Solomon received support for this work from the NIH (K24-AR-055989). Elizabeth W. Karlson received support for this work from NIH (K24-AR-AR0524). Reuma.pt received unrestricted grants from Abbott, Bristol-Myers Squibb, Merck Sharp and Dohme, Pfizer, Roche, and UCB Pharma. [1]
      This work was supported by the Fondo de Investigaciones Sanitarias (FIS, Instituto de Salud Carlos III), [grant number PI080704]; Consejería de Salud (SAS), Junta de Andalucía, [grant number SAS111213] and Ciberehd (Ciber de Enfermedades Hepáticas y Digestivas (Instituto de Salud Carlos III). [1]
      This work was supported by the Ministry of the Economy and Competitiveness of Spain, National Project I+D+I (FEM2016-79049-R) to SMH. [1]
      This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2015-66761-P; IPT-010000-2010-36, cofunded by the European Regional Development Fund), Consejería de Innovación, Ciencia y Tecnología, Junta de Andalucía (Spain) (P12-BIO-1395) and the Cooperative Research Thematic Network (RETICS) programme (RD16/0012/0013) (RIER) from Instituto de Salud Carlos III (ISCIII, Spanish Ministry of Economy, Industry and Competitiveness). AM is recipient of a Miguel Servet fellowship (CP17/00008) from ISCIII (Spanish Ministry of Economy, Industry and Competitiveness). DGS was supported by the Spanish Ministry of Economy and Competitiveness through the FPI programme (SAF2015-66761-P). This work is part of the Doctoral Thesis “Bases Genéticas de la Esclerosis Sistémica: Integrando Genómica y Transcriptómica”. [1]
      This work was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services; project ZO1 AG000949 [1]
      Tier 1 Canadian Research Chair in Stem Cells and Tissue Engineering and a Research Chair on Tissue-Engineered Organs and Translational Medicine from the Fondation de l’Université Laval [1]